Contract #HHSN272201800011I IDT biologika FY21 process development and master bank production for a staph aureus, SPA
Ended Awarded Last action
- Contract number
- 75N93021F00001
- Awardee
-
IDT Biologika GMBH UEI E14GD5J873N9
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $883,131
Award facts
- Contract value 100% obligated
- $883,131.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$265,880 | |
| Terminate for Convenience | $0 | |
| Original award | $1,149,011 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to IDT Biologika GMBH on August 19, 2021, with a ceiling value of $883,131.00 for process development and master bank production for Staphylococcus aureus protein A.
The order addresses de-obligation of unexpended and expiring fiscal year 2021 funding in preparation for September 30, 2026, closing of the period of availability. Place of performance is Rockville, Maryland. The ultimate completion date is April 18, 2025. Pricing is firm fixed price with no set-aside used.
Service Contract Inventory data for fiscal year 2023 shows 1.1 FTEs deployed across 2,196 contractor hours, with government-paid invoiced rates of $171.43 per hour. IDT Biologika self-performed all reported labor with no subcontractors engaged.
Quick answers
Who was awarded contract 75N93021F00001?
75N93021F00001 was awarded to IDT Biologika GMBH by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 19, 2021.
How much is contract 75N93021F00001 worth?
The government has obligated $883,131 on 75N93021F00001.
Is contract 75N93021F00001 an order under another contract?
Yes. 75N93021F00001 is a delivery order under 75N93018D00011, an indefinite delivery contract.
Was contract 75N93021F00001 competed?
The extent of competition for 75N93021F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award